Jeff Yass’s Theratechnologies THTX Stock Holding History

Jeff Yass’s Portfolio THTX Stock Details THTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-80,674	Closed	-$190K	–	13876
2025 Q2	$190K	Buy	+80,674	New	+$198K	﹤0.01%	11262

Other funds holding THTX

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Greatmark Investment Partners Columbus, Georgia $906M AUM 16.08% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Global Retirement Partners San Rafael, California $6.54B AUM

Jeff Yass's THTX Position: Q3 2025 in Review

Jeff Yass sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 80,674 shares — an estimated $190K sold.

Jeff Yass first reported a position in THTX in Q2 2025 and held it in 1 quarter. The position peaked at $190K in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

Jeff Yass reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
Jeff Yass sold 80,674 Theratechnologies shares in Q3 2025, an estimated $190K.
Jeff Yass first reported a position in Theratechnologies in Q2 2025 and held it in 1 quarter.
Jeff Yass's Theratechnologies position peaked at $190K in Q2 2025.
10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.